|Status : Published||Published On : Dec, 2021||Report Code : VRHC1045||Industry : Healthcare||Available Format :||Page : 250|
The global surgical site infection prevention market was valued at USD 4.4 billion in 2020 and is anticipated to reach to USD 6.85 billion by 2027, registering a CAGR of 6.5% during the forecast period 2021-2027. Surgical site infection is a septicity that arises after surgery which can include the skin or tissues, organs, or implanted material. The global surgical site infection prevention market is growing at a significant rate, due to mounting occurrence of surgical site infection, innovation of technologically advanced products. Different products contributed to the surgical site infection prevention market size. The market has witnessed high demand for antibiotic prophylaxis over the last few years as it is preventive measure that healthcare facilities implement to prevent infection and contamination throughout the treatment.
Insight by Product
On the basis of product the surgical site infection prevention market is subdivided into wound care dressings, antibiotic prophylaxis products, clippers, surgical drapes, antiseptics and disinfectants, surgical staff clothing, patient-warming products, wound irrigation products, wound care supplementary products and others. Of all product, antibiotic prophylaxis products accounted largest share in the market as it is the most popular type of preventive measure that healthcare facilities implement to prevent infection and contamination throughout the treatment. In addition, antiseptics and disinfectants are expected to grow at fastest rate in the market.
Insight by Phases
On the basis of phase the market is subdivided into postoperative phase, preoperative phase and intraoperative phase. Elevated quantity of products exhausted to mitigate the possibilities of infection and adherence of healthcare professionals to infection-control rules are some of the factors responsible for the growth of the intraoperative phase. Of all the phase, the intraoperative phase accounted foremost share in the surgical site infection prevention market.
Insight by End User
The different end-users of the market are ambulatory surgery centers, hospitals, clinics and others. Mounting inclination towards ambulatory surgery centers owing to boosting privacy during the stay is the factor growing the demand of surgical site infection prevention in ambulatory surgery centers. Among all end-users, ambulatory surgery centers are expected to grow at fastest rate in the surgical site infection prevention market.
The innovation of technologically advanced products, mounting hospital acquired infection, expanding regulatory guidelines for hospital infection prevention, and mounting number of surgical procedures are the primary growth drivers for surgical site infection prevention market. For instance, according to American Society of Plastic Surgeons in 2015 approximately 15.9 million cosmetic procedures were performed in the U.S., a two percent increase over 2014.
Mounting occurrence of surgical site infection is also driving the growth of the market. For instance, according to World Health Organization (WHO), approximately 11 percent of patients who endure surgery are infected in the procedure in low and middle-income countries.
Mounting initiatives by several organizations, mounting healthcare expenditure and expanding geriatric population are also facilitating the growth for the surgical site infection prevention market. For instance, according to WHO, globally in 2010 approximately 524 million people were aged 65 years and older, and is expected to reach 1.5 billion in 2050.
The less preventive methods for nosocomial infections in developing countries, lack of alertness about surgical site infection and lack of alertness of hospital-acquired infection prevention and control are the major challenges for the growth of surgical site infection prevention market.
Globally, the manufacturing companies trying to enter the surgical site infection prevention market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.
Geographically, North America is the largest surgical site infection prevention market as in the region the number of surgical procedure is increasing. Expanding geriatric population, technological advancement of advanced products are also up surging growth of the North American surgical site infection prevention market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.
Asia-Pacific is observed to witness the fastest growth in the market, as the region comprises a large population base. In addition, mounting healthcare expenditure, the mounting number of surgical procedures, expanding the geriatric population, mounting occurrence of surgical site infection, and refining healthcare infrastructure are also creating a positive impact on the surgical site infection prevention market growth in the region.
Key players in the surgical site infection prevention market are catering to the demand for these devices by investing in technologically advanced products in their product portfolio across the globe. In July 2018, Mölnlycke, acquired SastoMed GmbH, to help patients and healthcare professionals by treating chronic wounds and speeding up the wound healing process. In addition in December 2017, Prescient Surgical, Inc., received FDA approval for CleanCision, a wound retraction, and protection system in the U.S.
3M Company, Medtronic plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Covalon Technologies Ltd., Stryker Corporation, Becton, Dickinson and Company, Prescient Surgical Inc., Surgical Site Infection Prevention LLC, and STERIS plc are the key players offering surgical site infection prevention.
Source: VynZ Research